Metraipolis › archive › dc_34fd02739770

Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies — Europe PMC PMID:42423859

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42423859
DOI
10.1007/s12311-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-08T09:45:47.422Z
SHA-256 of the archived text
cf3db1cbbf021c58815fa9a270bcda187cf76bf08739f8c157d0e7ad388ce4df
Stable URL of this page
https://metraipolis.com/documento/dc_34fd02739770

How to cite

Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies — Europe PMC PMID:42423859 — Europe PMC (en), https://europepmc.org/article/MED/42423859 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34fd02739770 (Metraipolis archive dc_34fd02739770, sha256 cf3db1cbbf021c58815fa9a270bcda187cf76bf08739f8c157d0e7ad388ce4df)
BibTeX
@misc{dc34fd02739770,
  title = {Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies — Europe PMC PMID:42423859},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42423859},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34fd02739770; sha256 cf3db1cbbf021c58815fa9a270bcda187cf76bf08739f8c157d0e7ad388ce4df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42423859. Agents can read the archived copy with the MCP tool read_document.